KEGG pathway screening (p < 0.05) identified 30 significantly enriched signaling pathways, including lipid and atherosclerosis, PI3K-Akt signaling, atherosclerosis, hepatitis B, diabetic complications, human cytomegalovirus infection, cellular senescence, small cell lung cancer, and endocrine resistance. The gene discussed is AKT1; the disease is atherosclerosis.